Orix (IX) EBITDA Margin (QoQ) (2009 - 2026)
Powered by 
Analysis
Orix (IX) EBITDA Margin (QoQ) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Orix | 43.64 Bn | 43.64 Bn | 4.68 Bn |
| 2 | Royalty Pharma | 26.15 Bn | 25.32 Bn | - |
| 3 | Royal Gold | 21.54 Bn | 21.36 Bn | 390.45 Mn |
| 4 | OR Royalties | 6.72 Bn | 6.64 Bn | 82.22 Mn |
| 5 | Encore Capital | 2.11 Bn | 1.93 Bn | 455.04 Mn |
| 6 | Atlanticus Holdings | 1.41 Bn | 857.38 Mn | 686.46 Mn |
| 7 | Jefferson Capital | 1.18 Bn | 1.15 Bn | - |
| 8 | Upbound | 1.06 Bn | 953.54 Mn | 594.84 Mn |
| 9 | Lufax Holding | 1.05 Bn | -1.58 Bn | - |
| 10 | Burford Capital | 962.26 Mn | 962.26 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 552.00 |
| Mar 31, 2026 | -486.00 |
| Dec 31, 2025 | -43.00 |
| Sep 30, 2025 | -101.00 |
| Jun 30, 2025 | 1,035.00 |
| Mar 31, 2025 | -2,328.00 |
| Dec 31, 2024 | 2,509.00 |
| Sep 30, 2024 | -828.00 |
| Jun 30, 2024 | -4,837.00 |
| Mar 31, 2024 | 4,637.00 |
| Dec 31, 2023 | 235.00 |
| Sep 30, 2023 | -43.00 |
| Jun 30, 2023 | -3,583.00 |
| Mar 31, 2023 | 3,398.00 |
| Dec 31, 2022 | 463.00 |
| Sep 30, 2022 | -326.00 |
| Jun 30, 2022 | 1,106.00 |
| Mar 31, 2022 | -1,000.00 |
| Dec 31, 2021 | -522.00 |
| Sep 30, 2021 | 15.00 |